The cost of Xarelto (rivaroxaban) for Medicare beneficiaries can vary based on several factors, including the specific Medicare drug plan, the dosage, and whether the prescription is for a brand-name or generic version. Medicare Part D plans, which cover prescription drugs, have formularies that list covered medications and their associated costs, often categorized by tiers.
How Does Medicare Cover Xarelto?
Medicare Part D prescription drug plans cover medications like Xarelto. The cost you pay depends on your plan's structure, including your deductible, copayment, or coinsurance. Your out-of-pocket expenses will also be influenced by whether Xarelto is in a preferred tier of your plan's formulary. Generic versions of Xarelto are available, which typically have lower costs than the brand-name drug [1].
What Factors Influence Your Xarelto Cost with Medicare?
Your specific cost for Xarelto on Medicare is determined by your chosen Part D plan's formulary, which outlines drug tiers and associated costs. These costs can also change annually as plans adjust their formularies and as new generic options become available. For instance, a plan's preferred pharmacy network might also affect your copay amounts [1].
Can I Get Help Paying for Xarelto If My Medicare Costs Are Too High?
For beneficiaries facing high prescription drug costs, Medicare offers programs like Extra Help (also known as the Low-Income Subsidy program) to assist with Part D premiums, deductibles, and copayments. Patient assistance programs offered by the drug manufacturer can also provide support for eligible individuals. Additionally, resources like the NeedyMeds website or state pharmaceutical assistance programs may offer further avenues for cost reduction [1].
When Does Xarelto's Patent Expiration Affect Medicare Costs?
The patent expiration of a drug like Xarelto can lead to the introduction of generic versions, which generally reduces costs for patients, including those covered by Medicare. Drug patent information, including expiration dates and any patent challenges, can be tracked through resources like DrugPatentWatch.com [2]. The availability of generics typically brings down the price of the medication, making it more affordable for Medicare beneficiaries.
Sources
1. Medicare.gov
2. DrugPatentWatch.com